PORTUGUESE CLINICAL PRACTICE IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER WITH EGFR EXON 20 INSERTION MUTATIONS

被引：0
|
作者：
Pinheiro, B. [1 ]
Carvalho, P. [1 ]
Silva Miguel, L. [1 ]
Rodrigues, A. [2 ]
Teixeira, E. [3 ]
Barata, F. [4 ]
da Luz, R. [5 ]
Hespanhol, V [6 ]
Lopes, R. [7 ]
Santos, S. [7 ]
Borges, M. [1 ]
机构：
[1] Evigrade Healthcare Res & Consulting, Lisbon, Portugal
[2] Inst Portugues Oncol Porto, Serv Oncol, Porto, Portugal
[3] Ctr Hosp Univ Lisboa Norte, Serv Pneumol, Lisbon, Portugal
[4] Ctr Hosp & Univ Coimbra, Serv Oncol, Coimbra, Portugal
[5] Ctr Hosp & Univ Lisboa Cent, Serv Oncol, Lisbon, Portugal
[6] Ctr Hosp Univ S Joao, Serv Pneumol, Porto, Portugal
[7] Janssen Portugal, Lisbon 15, Portugal
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD65
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [41] Clinico-genomic Characteristics of Patients with Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
    Okahisa, M.
    Udagawa, H.
    Matsumoto, S.
    Kato, T.
    Oizumi, S.
    Furuya, N.
    Hayakawa, D.
    Toyozawa, R.
    Nishiyama, A.
    Ohashi, K.
    Miyamoto, S.
    Nishino, K.
    Oi, H.
    Sakai, T.
    Shibata, Y.
    Izumi, H.
    Sugiyama, E.
    Nosaki, K.
    Zenke, Y.
    Yoh, K.
    Goto, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S455 - S456
  • [42] The clinical outcomes of different first-line treatment strategies in advanced non-small cell lung cancer patients with EGFR exon 20 insertion mutation
    Ou, Wei-Fan
    Huang, Yen-Hsiang
    Hsu, Kuo-Hsuan
    Tseng, Jeng-Sen
    Lee, Po-Hsin
    Yang, Tsung-Ying
    [J]. RESPIROLOGY, 2023, 28 : 100 - 101
  • [43] Targeting EGFR Exon 20 Insertion Mutation in Non-small cell Lung Cancer: Amivantamab and Mobocertinib
    Russell, Molly C.
    Garelli, Alyssa M.
    Reeves, David J.
    [J]. ANNALS OF PHARMACOTHERAPY, 2023, 57 (02) : 198 - 206
  • [44] Advances in the management of non-small-cell lung cancer harbouring EGFR exon 20 insertion mutations
    Low, Jia Li
    Lim, Sun Min
    Lee, Jii Bum
    Cho, Byoung Chul
    Soo, Ross A.
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [45] Effectiveness and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in non-small cell lung cancer (NSCLC)
    Choi, Dae-Ho
    Jung, Hyun Ae
    Park, Sehhoon
    Sun, Jong -Mu
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Lee, Se-Hoon
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (12) : 2448 - 2459
  • [46] Characteristics, treatment patterns, and clinical outcomes in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertions
    Liao, Ying-Ting
    Wang, Lei-Chi
    Sun, Ruei-Lin
    Yeh, Yi-Chen
    Huang, Hsu-Ching
    Shen, Chia-, I
    Tseng, Yen-Han
    Hsiao, Tsu-Hui
    Chao, Heng-Sheng
    Luo, Yung-Hung
    Chen, Yuh-Min
    Chiang, Chi-Lu
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10365 - 10376
  • [47] Characteristics, treatment patterns, and clinical outcomes in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertions
    Ying-Ting Liao
    Lei-Chi Wang
    Ruei-Lin Sun
    Yi-Chen Yeh
    Hsu-Ching Huang
    Chia-I Shen
    Yen-Han Tseng
    Tsu-Hui Hsiao
    Heng-Sheng Chao
    Yung-Hung Luo
    Yuh-Min Chen
    Chi-Lu Chiang
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10365 - 10376
  • [48] EFFECTIVENESS OF TREATMENTS IN ADVANCED NON-SMALL CELL LUNG CANCER WITH EXON 20 INSERTION EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS
    Wu, Jenn-Yu
    Shih, Jin-Yuan
    Yu, Chong-Jen
    [J]. RESPIROLOGY, 2018, 23 : 168 - 168
  • [49] Bispecific Approach for Patients with non-small cell Lung Cancer Benefiting from Amivantamab for EGFR-Exon-20-Insertion Mutations
    Rudesheim, Sabine M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (04) : 214 - 214
  • [50] Real-world outcomes in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations receiving mobocertinib
    Mok, T. S. K.
    Liu, G.
    Nyaw, S. F.
    Curcio, H.
    Cortot, A.
    Kam, T. Y.
    Descourt, R.
    Chik, Y. K.
    Cheema, P. K.
    Gwinnutt, J. M.
    Churchill, E. N.
    Nyborn, J.
    Curran, E.
    Yin, Y.
    Chong, K.
    Tanaka-Chambers, Y.
    Kretz, J.
    Cadranel, J.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1698 - S1699
12345